Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial

Completed

Conditions studied: Cardiorenal Syndrome, Acute Decompensated Heart Failure

In brief

The purpose of this study is to evaluate the ability of a non-invasive monitor that measures how much fluid is in the body as well as various blood tests for their ability to predict worsening kidney function in patients with heart failure.

Key facts

Study ID

NCT01570153

Run by

Massachusetts General Hospital

People needed

100

Starts

2012-03-01

Expected to finish

2013-11-01

Last updated by the study team

2014-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Dyspnea thought to be due to ADHF
• NYHA class III or IV symptoms

You may not qualify if…

• renal failure requiring renal replacement therapy rior to enrollment
• unable or unwilling to participate
• > 6 hours from first dose of intravenous diuretic

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States
• Ospedale Sant'Andrea — Rome, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.